Medtronic Pays $12M To 5 States For Deceptive Marketing Of Infuse Bone Graft

(December 14, 2017, 1:45 PM EST) -- BOSTON — Medtronic Inc. has agreed to pay $12 million to five states to resolve allegations that it engaged in deceptive marketing of the company’s Infuse bone graft, according to a...
To view the full article, register now.